Technical Analysis for MDSO - Medidata Solutions, Inc.

Grade Last Price % Change Price Change
grade B 75.84 0.00% 0.00
MDSO closed unchanged on Monday, March 25, 2019, on 89 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical MDSO trend table...

Date Alert Name Type % Chg
Mar 25 200 DMA Support Bullish 0.00%
Mar 25 20 DMA Support Bullish 0.00%
Mar 22 Slingshot Bullish Bullish Swing Setup 0.00%
Mar 22 Upper Bollinger Band Walk Strength 0.00%
Mar 22 Overbought Stochastic Strength 0.00%
Mar 22 Upper Bollinger Band Touch Strength 0.00%
Mar 21 Stochastic Sell Signal Bearish -5.22%
Mar 21 Expansion Breakout Bullish Swing Setup -5.22%
Mar 21 Upper Bollinger Band Walk Strength -5.22%
Mar 21 Multiple of Ten Bullish Other -5.22%

Older signals for MDSO ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Medidata Solutions, Inc. provides cloud-based clinical development solutions for life sciences organizations in the United States and internationally. The company's solutions comprise software and services that allow customers to increase the value of their clinical development by designing, planning, and managing key aspects of the clinical trial process, including study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, clinical data capture and management, safety events capture, medical coding, clinical business analytics, and data flow and interoperability. It offers Medidata Rave, a platform for capturing and managing clinical data; Medidata CTMS, a clinical trial management solution that streamlines operational workflows; Medidata Designer, a study and protocol design tool that enhances the efficiency of clinical trial start-up; Medidata Insights, a business analytics platform; and Medidata Balance, a randomization and trial supply management solution. The company also provides Medidata Grants Manager, which enables to develop and manage trial budgets; Medidata contract research organization (CRO) Contractor, an analytical tool for CRO outsourcing, budgeting, and negotiation; and iMedidata, a hosted portal application that allows investigative sites and sponsor study teams to start trial activities. In addition, it offers hosting, support, and professional services. The company serves pharmaceutical, biotechnology, medical device, and diagnostics companies, as well as institutions, clinical research organizations, and other entities engaged in clinical trials. Medidata Solutions, Inc. markets and sells its application services through a direct sales force, as well as through relationships with CROs and other strategic partners. The company was founded in 1999 and is headquartered in New York, New York.
Health Biotechnology Pharmaceutical Industry Clinical Trial Clinical Research Medical Research Clinical Data Management Analytical Tool Contract Research Organization Medidata Solutions
Is MDSO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 88.87
52 Week Low 60.1
Average Volume 482,430
200-Day Moving Average 74.8756
50-Day Moving Average 72.9938
20-Day Moving Average 75.3175
10-Day Moving Average 76.57
Average True Range 2.0788
ADX 16.04
+DI 24.6025
-DI 21.424
Chandelier Exit (Long, 3 ATRs ) 73.9936
Chandelier Exit (Short, 3 ATRs ) 77.5964
Upper Bollinger Band 79.165
Lower Bollinger Band 71.47
Percent B (%b) 0.57
BandWidth 10.216749
MACD Line 1.1384
MACD Signal Line 1.0822
MACD Histogram 0.0562
Fundamentals Value
Market Cap 4.29 Billion
Num Shares 56.6 Million
EPS 0.62
Price-to-Earnings (P/E) Ratio 122.32
Price-to-Sales 8.38
Price-to-Book 9.63
PEG Ratio 2.80
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 78.08
Resistance 3 (R3) 77.89 76.96 77.70
Resistance 2 (R2) 76.96 76.39 77.05 77.58
Resistance 1 (R1) 76.40 76.04 76.68 76.59 77.45
Pivot Point 75.47 75.47 75.61 75.56 75.47
Support 1 (S1) 74.91 74.90 75.19 75.10 74.23
Support 2 (S2) 73.98 74.55 74.07 74.10
Support 3 (S3) 73.42 73.98 73.98
Support 4 (S4) 73.61